AUTODERM identifies 5% of all UK melanoma cases using artificial intelligence
BARCELONA/LONDON, (17th June 2024) — AUTODERM is a research backed Software as a Medical Device (SaMD), using artificial intelligence (AI) in dermatology. In May, 18359 skin ailments were analysed, it found 80 possible melanomas, 95 squamous cell carcinomas and 202 basal cell carcinomas, via the integration in the myGP app by iPlato.
In May 2024 we performed our Post-Market Clinical Follow-up (PMCF), which is a proactive collection of data required by the Medical Device Regulation (MDR) to demonstrate device safety. You can read the full report here.
Eighty possible melanomas were found that represent 2-3 malignant melanomas per day. According to a report by Cancer Research UK, 46 melanomas are diagnosed on a daily basis in the UK. The 80 melanomas represent about 5% of the number of melanomas found in the UK on a monthly basis.
Since its integration into the myGP app, AUTODERM has scanned over 370,000 mobile phone skin images. On average, around 500-600 individuals use the skin scanner daily, highlighting its popularity.
“With many years of research and developing AUTODERM, we do a regular quality assessment of the data that is generated”, says CEO Dr Börve, a researcher and a pioneer in digital dermatology. “I am very proud of my team and the partnership with iPlato, which lets us reach millions of UK citizens. The results from our PMCF highlights an example where AI in healthcare has clear benefits” - Dr. Börve
The AI engine is designed to deliver high accuracy in its assessments, providing users with quick and reliable results. This efficiency is crucial for early detection and timely intervention, which can significantly improve patient outcomes. The AI model has been researched in a clinical GP setting and the results published in Nature. The accuracy was on par with experienced GPs, but it was not as good as a tele-dermatologist. However a GP with the aid of AUTODERM as a decision support tool could have prevented 34% referrals to a dermatologist and it helped the GP diagnose patients correctly in 60% of the skin disease cases.
Nota Bene
Using AI to screen for skin ailments is not intended to substitute a GP or a dermatologist, but help with patient awareness, education and get them into a GP office without delay for a definite diagnosis and care.
About AUTODERM
AUTODERM is a clinical research backed artificial intelligence (AI) dermatology analytics engine, CE marked and registered with the MHRA. With a proprietary database of amateur smartphone images of skin diseases, they make AI models in dermatology. The AI models are accessible via an API and can be integrated into any platform. The intended use is as a decision support tool for healthcare providers and a triage / informational tool for the layman.
BARCELONA/LONDON, (17th June 2024) — AUTODERM is a research backed Software as a Medical Device (SaMD), using artificial intelligence (AI) in dermatology. In May, 18359 skin ailments were analysed, it found 80 possible melanomas, 95 squamous cell carcinomas and 202 basal cell carcinomas, via the integration in the myGP app by iPlato.
In May 2024 we performed our Post-Market Clinical Follow-up (PMCF), which is a proactive collection of data required by the Medical Device Regulation (MDR) to demonstrate device safety. You can read the full report here.
Eighty possible melanomas were found that represent 2-3 malignant melanomas per day. According to a report by Cancer Research UK, 46 melanomas are diagnosed on a daily basis in the UK. The 80 melanomas represent about 5% of the number of melanomas found in the UK on a monthly basis.
Since its integration into the myGP app, AUTODERM has scanned over 370,000 mobile phone skin images. On average, around 500-600 individuals use the skin scanner daily, highlighting its popularity.
“With many years of research and developing AUTODERM, we do a regular quality assessment of the data that is generated”, says CEO Dr Börve, a researcher and a pioneer in digital dermatology. “I am very proud of my team and the partnership with iPlato, which lets us reach millions of UK citizens. The results from our PMCF highlights an example where AI in healthcare has clear benefits” - Dr. Börve
The AI engine is designed to deliver high accuracy in its assessments, providing users with quick and reliable results. This efficiency is crucial for early detection and timely intervention, which can significantly improve patient outcomes. The AI model has been researched in a clinical GP setting and the results published in Nature. The accuracy was on par with experienced GPs, but it was not as good as a tele-dermatologist. However a GP with the aid of AUTODERM as a decision support tool could have prevented 34% referrals to a dermatologist and it helped the GP diagnose patients correctly in 60% of the skin disease cases.
Nota Bene
Using AI to screen for skin ailments is not intended to substitute a GP or a dermatologist, but help with patient awareness, education and get them into a GP office without delay for a definite diagnosis and care.
About AUTODERM
AUTODERM is a clinical research backed artificial intelligence (AI) dermatology analytics engine, CE marked and registered with the MHRA. With a proprietary database of amateur smartphone images of skin diseases, they make AI models in dermatology. The AI models are accessible via an API and can be integrated into any platform. The intended use is as a decision support tool for healthcare providers and a triage / informational tool for the layman.
